Artivion Announces Release Date and Teleconference Call Details for Third Quarter 2025 Financial Results

Rhea-AI Summary

Artivion (NYSE: AORT) will release third quarter 2025 financial results on Thursday, November 6, 2025 after market close, with a teleconference and live webcast at 4:30 p.m. ET.

Pat Mackin, Chairman, President and CEO, will host the call and Q&A. To join live, dial 201-689-8261 a few minutes before 4:30 p.m. ET. A replay will be available about one hour after the event via toll-free 877-660-6853 or 201-612-7415 using conference number 13755945. The live webcast and replay and the earnings press release with financial and statistical information will be accessible in the Investors section at www.artivion.com under Webcasts & Presentations.

ATLANTA, Oct. 23, 2025 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, announced today that third quarter 2025 financial results will be released on Thursday, November 6, 2025, after the market closes. On that day, the Company will hold a teleconference call and live webcast at 4:30 p.m. ET to discuss the results, followed by a question-and-answer session hosted by Pat Mackin, Chairman, President and Chief Executive Officer of Artivion.

To listen to the live teleconference, please dial 201-689-8261 a few minutes prior to 4:30 p.m. ET. The teleconference replay will be available approximately one hour following the completion of the event and can be accessed by calling (toll free) 877-660-6853 or 201-612-7415. The conference number for the replay is 13755945. 

The live webcast and replay can be accessed on the Investors section of the Artivion website at www.artivion.com and by selecting Webcasts & Presentations. In addition, a copy of the earnings press release, which will contain financial and statistical information for the completed quarter and full year, can be accessed in the Investors section of the Artivion website.

About Artivion, Inc.
Headquartered in suburban Atlanta, Georgia, Artivion, Inc. is a medical device company focused on developing simple, elegant solutions that address cardiac and vascular surgeons' most difficult challenges in treating patients with aortic diseases. Artivion's four major groups of products include: aortic stent grafts, surgical sealants, On-X mechanical heart valves, and implantable cardiac and vascular human tissues. Artivion markets and sells products in more than 100 countries worldwide. For additional information about Artivion, visit our website, www.artivion.com.

Contacts:

Artivion Lance A. Berry Executive Vice President, Chief Operating Officer & Chief Financial Officer Phone: 770-419-3355

Gilmartin Group LLC Brian Johnston Laine Morgan Phone: 332-895-3222 investors@artivion.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/artivion-announces-release-date-and-teleconference-call-details-for-third-quarter-2025-financial-results-302593266.html

SOURCE Artivion, Inc.

FAQ

When will Artivion (AORT) report third quarter 2025 results?

Artivion will release third quarter 2025 results Thursday, November 6, 2025 after market close.

What time is the Artivion (AORT) earnings call and webcast on November 6, 2025?

The teleconference and live webcast are scheduled for 4:30 p.m. ET on November 6, 2025.

How can investors join the Artivion (AORT) live teleconference on November 6, 2025?

Dial 201-689-8261 a few minutes prior to 4:30 p.m. ET to listen live.

How can I access the replay of Artivion's (AORT) November 6, 2025 earnings call?

A replay will be available about one hour after the event via toll-free 877-660-6853 or 201-612-7415 using conference number 13755945.

Where will Artivion (AORT) post the Q3 2025 earnings press release and webcast replay?

Both the earnings press release and the live webcast/replay will be posted in the Investors section at www.artivion.com under Webcasts & Presentations.